Health Discovery Corporation

01/21/2026 | Press release | Distributed by Public on 01/21/2026 10:44

Material Event (Form 8-K)

Item 8.01 Other Events

On December 31, 2025, Health Discovery Corporation (the "Company") filed a patent infringement lawsuit against NVIDIA Corporation ("NVIDIA") in the United States District Court for the District of Delaware. The lawsuit seeks legal and equitable relief based on NVIDIA's unlawful infringement of U.S. Patent No. 10,402,685 (the "'685 Patent") which generally relates to Recursive Feature Elimination Method Using Support Vector Machines for selecting features from a dataset to improve pattern recognition and classification tasks.

The claimed invention of the '685 Patent introduces a recursive training and elimination process that systematically ranks data features by their contribution to model accuracy and removes the least significant ones. This approach allows a learning system not only to classify data, but to intelligently refine the data representation itself, thereby yielding a more efficient, interpretable and generalizable model.

In summary, the lawsuit asserts that NVIDIA infringes, at least, representative method claim 1 of the '685 Patent through its GPU-accelerated machine-learning stack. The '685 Patent expired on or about June 27, 2025, but the Company is seeking damages and other relief for the period for which the statute of limitations on the infringement claim has not yet expired. The Company is seeking, among other relief, trebled damages based on NVIDIA's willful and deliberate infringement.

There can be no assurance as to the outcome of this litigation or the timetable for bringing this case to trial.

Health Discovery Corporation published this content on January 21, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on January 21, 2026 at 16:44 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]